The goal of the Early Detection of Pancreatic Cancer Laboratory is to identify molecular abnormalities that can improve the outcome of patients with pancreatic cancer and those at risk of developing this disease. Much of our work is focused on translational research evaluating markers and marker technologies that can help screen patients with an increased risk of developing pancreatic cancer. Ongoing translational research programs include the Cancer of the Pancreas Screening-5, or “CAPS5” multicenter study which is supported by a U01 and R01 grant from the National Cancer Institute and a  Stand Up to Cancer Award aimed at pancreatic cancer early detection.